Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01312428 · ClinicalTrials.gov registry record · NA
Pelvic Alignment Level (PAL) Instrument Evaluation
A NA study, sponsored by Stryker Orthopaedics.
- Terminated
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT01312428: Clinical Trial NA study, sponsored by Stryker Orthopaedics.
NCT01312428 is a NA study that was terminated before completion, run by Stryker Orthopaedics. The registered enrollment target is 7 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01312428, a NA study, was terminated before completion, sponsored by Stryker Orthopaedics.
- TERMINATED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
The study is conducted to evaluate the performance of the Pelvic Alignment Level (PAL) instrument in achieving desired acetabular position, desired leg length and offset after Total Hip Replacement (THR) reconstruction.
Interventions
- DEVICE Pelvic Alignment Level (PAL) Instrument
- DEVICE No Pelvic Alignment Level (PAL) Instrument
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2011-02 |
| Est. Completion | 2012-04 |
| Phase | NA |
Why NCT01312428 stopped before completion
NCT01312428 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Pelvic Alignment Level (PAL) Instrument is the first listed.
NCT01312428 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01312428 about?
NCT01312428 is a clinical study titled "Pelvic Alignment Level (PAL) Instrument Evaluation". The study is conducted to evaluate the performance of the Pelvic Alignment Level (PAL) instrument in achieving desired acetabular position, desired leg length and offset after Total Hip Replacement (THR) reconstruction.
What is the current status of trial NCT01312428?
This trial is currently terminated. It is a NA study. The enrollment target is 7 participants. The study started on 2011-02. Estimated completion is 2012-04.
What interventions are being tested in trial NCT01312428?
The interventions under investigation include: Pelvic Alignment Level (PAL) Instrument (DEVICE), No Pelvic Alignment Level (PAL) Instrument (DEVICE).
Who is sponsoring clinical trial NCT01312428?
This trial is sponsored by Stryker Orthopaedics, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01312428's enrollment target sits among peer trials
7 1982nd of 2000 higher than 18 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia